This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

FINANCIAL STATEMENTS 31 DECEMBER 2024

Charity Number 1062067

COMPANY REGISTRATION NUMBER 03337359

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

CONTENTS	PAGE
Trustees’ Annual Report	3
Independent auditor's report to the members	22
Statement of financial activities (incorporating the
income and expenditure account)	26
Balance sheet	28
Statement of cash flows	29
Notes to the financial statements	30
The following pages do not form part of the financial	statements
Detailed statement of financial activities	47

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

REFERENCE AND ADMINISTRATIVE DETAILS

Trustees and Directors

For the purposes of charity and company law and in accordance with the Association’s governing document, the trustees of the charity and the directors of the company are certain executive officers of the Council of the Association. The trustees and directors that have held office since 1 January 2024 are as follows:

Professor Kathleen Fan President (from 1 July 2024) Vice President (to 30 June 2024) Miss Daljit K Dhariwal Immediate Past President ( from 1 July 2024 ) President (1 July 2023 to 30 June 2024) Mr Patrick Magennis Vice President (from 1 July 2024) President Designate (to 30 June 2024) Mr Robert J Banks Honorary Treasurer (appointed 1 January 2022) Mr Iain Varley Honorary Secretary and Company Secretary (appointed 1 July 2023)

The Council of the Association

The trustees and directors are assisted and advised by the other officers and members of the Council of the Association, who have held office since 1 January 2024, as follows:

Officers of Council

Mr Bhavin Visavadia President Designate (from 1 July 2024 to 30 June 2025) Professor Panayiotis Kyzas BJOMS Editor (appointed from 1 January 2024) Professor Peter A Brennan Chair of Council (from 1 January 2020) Mr David J W Keith Deputy Chair of Council (from 1 January 2024)

Members of Council

Miss Nabeela Ahmed (from 1 January 2022) Miss Anne Begley (from 1 January 2022 re-elected) Mr Montey Garg (from 1 January 2024) Miss Elizabeth Gruber (from 1 January 2022) Mr Dilip Srinivasan (from 1 January 2023) Professor Carrie Newlands (from 1 January 2022) Miss Harpreet Ark Associate Fellow (from 1 January 2022) Miss Jennifer Parrish Associate Fellow (from 1 January 2022) Mr Suresh Shetty Consultants and Specialists’ Group Chair (from 1 October 2021)

- 3 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

REFERENCE AND ADMINISTRATIVE DETAILS (continued)

Members of Council (continued)

Mr David J W Keith Consultants and Specialists’ Group Deputy Chair (from 1 October 2021) Mr Adam Holden Fellows in Training Representative (from 1 January 2024) Mr Amit Dattani Deputy Fellows in Training Representative (from 1 January 2024) Mr Richard Taylor Junior Trainees and Members’ Representative (from 1 January 2024) Ms Mairead Kelly Deputy Junior Trainees and Members’ Representative (from 1 January 2024)

The principal address of the charity and the registered office of the company is the offices of the Association at The Royal College of Surgeons of England, 38/43 Lincoln’s Inn Fields, London WC2A 3PE.

The charity is registered under the charity number 1062067, and the company is incorporated with the company registration number 03337359.

The trustees have made the following professional appointments:

Accountant: Hardcastle Burton Chartered Accountants, 36 Dene Road, Northwood, Middlesex HA6 2DA Auditor: Buzzacott LLP, 130 Wood Street, London EC2V 6DL Bankers: Lloyds TSB Bank plc, Kings Cross Branch, 344 Gray’s Inn Road, London WC1X 8BX

Investment Manager: Cazenove Capital Management wealth management from Schroders, 12 Moorgate, London EC2A 6DA Solicitor: Hempsons London, Hempsons House, 40 Villiers Street, London WC2N 6NJ

The following key members of staff are responsible for the day-to-day management of the charity:

Ms Sarah Durham Senior Administrator Mrs Dannielle Bellanca Assistant Administrator

- 4 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT

The trustees present their report and the financial statements of the British Association of Oral and Maxillofacial Surgeons (“The Association” or “BAOMS) for the year ended 31 December 2024. The financial statements have been prepared in accordance with the accounting policies set out on pages 30 to 34 of the financial statements and comply with the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applying to charities preparing their accounts in accordance with the Financial Reporting Standard in the United Kingdom and Republic of Ireland (FRS 102).

This report is a combined Company Directors and Charity Trustees annual report has been prepared to include all the information required by the SORP module ‘Trustees’ annual report’ and applicable charity law and also contains a directors’ report as required by company law.

Status and History

BAOMS is a registered charity, and a company limited by guarantee, not having share capital. Every member undertakes to contribute an amount not exceeding £1 to the assets of the charity in the event of the charity being wound-up during the period of membership, or within one year thereafter.

Oral and Maxillofacial Surgery originated in the United Kingdom as the surgical specialty of dentistry, developing from the need for specialist services to treat jaw injuries sustained by servicemen during the two World Wars. It soon became clear that the prevalence of civilian facial injuries in peace time was at least as great, largely due to the increasing use of motor cars and motorcycles.

The specialty of Oral and Maxillofacial Surgery evolved to meet the clear demand for treatment of an increasingly large range of pathological conditions of the face, jaws and teeth. The complexity of the specialty was reflected by a change of title from The British Association of Oral Surgeons to The British Association of Oral & Maxillofacial Surgeons in the year ended 30 June 1986.

The specialty Association was incorporated on 21 March 1997 and became a registered charity on 24 April 1997. BAOMS is governed by the rules and regulations set down in its company Memorandum and Articles of Association as last updated on 8 October 2021. As of January 2025, the Trustees and Council are reviewing the Memorandum and Articles of Association.

Organisational Structure and Key Management

The overall strategic direction of the charity is determined by the trustees, who are assisted and advised by the other officers and members of the Council of the Association.

The Council normally has 18 members, but additional individuals will be co-opted to attend for specific relevant matters. The Council meets four times a year. The Council members outside Chair, Deputy Chair and the Editor receive no remuneration for their work carried out on behalf of the Association. Travel expenses are paid for all members of Council, who carry out work on behalf of the Association on various committees and working parties in the United Kingdom and throughout Europe.

- 5 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Organisational Structure and Key Management (continued)

A Chair of Council is appointed by Council and holds office for a term of four years. The incumbent chairs the Council meetings and represents the Association on a number of committees. The role of Chair of Council is non-voting. The Chair of Council shall be appointed in the first instance as Deputy Chair of Council for a period of one year to run in parallel with the last year of office of the out-going Chair of Council.

The trustees consider that they, together with the Chair of Council and the Senior Administrator, comprise the key management of the charity in charge of directing and controlling, running and operating the charity on a day-to-day basis.

The Chair of Council, being a paid role, is remunerated by the Association to the equivalent of two Programmed Activities (units of paid clinical time in the NHS), the equivalent of one working day per week on basic salary. This amount is paid direct to the employing Trust or Organisation in recognition of clinical time spent on Association business. The Deputy Chairman (when in post) is normally remunerated with half a working day per week, again based on basic salary, and paid to their employing NHS Trust. The Editor, being a paid role, is remunerated by the Association to the equivalent of two Programmed Activities (units of paid clinical time in the NHS), the equivalent of one working day per week on basic salary. This amount is paid direct to the employing Trust or Organisation in recognition of clinical time spent on Association business. The Senior Administrator is employed by the Association. Staff salaries are discussed agreed annually at a Trustees meeting.

The day-to-day administration of the Association is carried out by Ms Sarah Durham, the Senior Administrator and Ms Dannielle Bellanca as Assistant Administrator.

Office space is rented from and based at the Royal College of Surgeons of England. Additional facilities, such as Human Resources advice, are ‘bought in’ from the Royal College of Surgeons of England, as and when the need arises. Post pandemic the office team have continued to work in the office and from home.

Daily correspondence is dealt with by the office staff and copies are circulated to the trustees and/or the Chair of Council, as appropriate, for comment and dissemination to Council as required. A detailed work plan is agreed annually between the Senior Administrator and the trustees, which sets out the major aims and activities for each year.

The Association’s key goals (such as maintaining funding for the Research Fund) are constant factors in any given year. Other factors include:

Developing strategy for recruitment and retention within the specialty;
Preparing for the four Council meetings (agendas and papers are agreed by the Chair of Council, and then collated and sent from the office);
Organising and enhancing the clinical content of Annual Scientific Meetings (both current and future years);
Invoicing and collecting annual Association subscriptions;
Maintaining Association membership records; and
• Observing the requirements and obligations of a charitable organisation.

- 6 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Council appoints a number of sub-committees to organise different areas of the Association’s activities as detailed below:

The Endowments sub-committee oversees the award of clinical and research grants and prizes during the year. The committee meets twice a year and considers applications from all categories of membership for approval by Council. Application for grants is governed by guidelines and an application process, which can be downloaded from the Association’s website at www.baoms.org.uk. A formal peer review process by two independent reviewers is organised for grants in excess of £10,000.

Organisational Structure and Key Management (continued)

The Clinical Effectiveness committee has now been replaced by Clinical Outcomes and the Quality and Outcomes in oral and Maxillofacial Surgery (QOMS) project. The project manager continues to deliver this work.
The Education and CPD sub-committee handles CPD accreditation and revalidation.
The Norman Rowe International Education Foundation (NRIEF) is responsible for work with overseas doctors arranging initiatives such as distance learning courses and humanitarian type initiatives.

In addition, Council spearheads initiatives relating to other education and research issues, public awareness and general promotion of the Specialty - as these are the central main objectives of the charity.

Method of Recruitment, Appointment, Election, Induction and Training of Trustees

Recruitment

Trustees are selected from past and present Council members (excluding retired Council members). The Honorary Secretary and the Honorary Treasurer may be recruited from the Fellows category of membership. An outline of the duties for each of the trustee positions is circulated to the relevant members of the Association.

Nominations are then submitted together with a supporting statement from the applicant. These are then considered and a trustee appointed at a Council meeting at least three months prior to the post becoming vacant.

Appointment and Election

Under the requirements of the Memorandum and Articles of Association, the members of Council are elected to serve for a period of three years. All eligible fellowship categories of the Association are circulated with an outline of the duties required and nomination forms are submitted along with a statement of intent, which is included with an online election and then circulated to eligible voting members of the Association. Following a change to the Memorandum and Articles of Association in October 2021, the Presidential handover/Term of office was changed from 1 January to 31 December to 1 July to 30 June to allow for the handover to take place at the Annual Scientific Meeting of the Association which is usually in June/July.

Induction and Training

Having accepted appointment, trustees are sent the main documents, which set out the operational framework of the Association, including the Memorandum and Articles of Association. In addition, trustees are directed to the Charity Commissions’ guide ‘the Essential Trustee’. On-going training for trustees is organised and provided by the Association as and when required. Demitting officers / trustees are encouraged to advise and inform new appointees where practicable.

- 7 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Risk and Corporate Governance Matters

The trustees have reviewed the major risks facing the Association, aiming to minimise the charity’s exposure to risk, whilst attending to its viability and ensuring its longevity. The management of risk is the responsibility of the whole board of trustees, who monitor exposure through regular contact with Council members and office staff. The Association carries a range of insurances, renewed annually, to cover the key insurable risks associated with the administration of the charity’s activities, and office procedures ensure that daily back-ups are run for all of the Association’s data, including information published on the website.

The trustees consider the key risk facing the Association to be loss of membership. If this were to happen on any significant scale, there would be no reason for the Association to continue in existence and no meetings would need to take place. They constantly review the incentives and recruitment initiatives to engage as many practitioners of OMFS as possible in Association membership categories. The Association also has a risk register which is reviewed and updated annually.

Statement of Trustees’ Responsibilities

The trustees (who are also the directors of The British Association of Oral and Maxillofacial Surgeons for the purposes of company law) are responsible for preparing the trustees’ annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the trustees to prepare financial statements for each financial year. Under that law, the Trustees have prepared financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

Under company law, the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company, and of the income and expenditure, of the charitable company for that period.

In preparing those financial statements, the trustees are required to:

select suitable accounting policies and then apply them consistently;
observe the methods and principles in the Accounting and Reporting by Charities: Statement of Recommended Practice;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed subject to any material departures disclosed and explained in the financial statements; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.

- 8 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STATEMENT OF TRUSTEES’ RESPONSIBILITIES (continued)

Statement of Trustees’ Responsibilities (continued)

The trustees are responsible for keeping proper accounting records that are sufficient to show and explain the charitable company’s transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from the legislation in other jurisdictions.

Auditor

The auditors, Buzzacott were re-appointed at the Annual General Meeting held on 3 July 2024.

Statement as to Disclosure of Information to the Auditor

The trustees at the date of approval of this trustees’ annual report confirm that so far as each of them is aware, there is no relevant audit information of which the charity’s auditor is unaware, and the trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.

Professional Indemnity Insurance

The charity has taken out a public liability insurance policy that provides professional indemnity cover (amounting to £500,000 in respect of any one claim) for the Council members (including the trustees) and the staff of the charity. The cost of this insurance policy to the charity for the year was £1,028 (2023: £1,548).

OBJECTIVES AND ACTIVITIES

Charitable Objectives

The charitable objectives for which the charity is established are as follows:

(a) To promote the advancement of education, research and the development of Oral and Maxillofacial Surgery in the British Isles.
(b) To encourage and assist postgraduate education, study and research in Oral and Maxillofacial Surgery by:
(i) Arranging regular meetings at which lectures and demonstrations will be given.
(ii) Encouraging the publication of articles on Oral and Maxillofacial Surgery either by publishing a special journal or by other means.
(iii) Ensuring that Oral and Maxillofacial Surgery is represented adequately as a specialty to both the Medical and Dental Professions.
(iv) Promoting the advancement of the theory and practice of Oral and Maxillofacial Surgery by any other means, which may from time to time be considered appropriate by the Council of the Association.
(v) To hold one annual scientific meeting and one joint meeting on topics of interest to allied specialty organisations.

- 9 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

OBJECTIVES AND ACTIVITIES (continued)

Charitable Activities

In order to meet its charitable objectives, the trustees have set an overall goal for the Association to do everything within it powers to promote and encourage education, study, research and development of Oral and Maxillofacial Surgery as a specialty.

In pursuance of its overall goal, the Association’s principal activity is the dissemination of information as it relates to the specialty.

Each year this activity is undertaken in a number of ways, including:

Encouraging membership of the Association;
Publishing The British Journal of Oral and Maxillofacial Surgeons (“BJOMS”);
Organising an Annual Scientific Meeting (“ASM”);
Organising, attending, and endorsing other ad hoc meetings; and
Funding Research and Training initiatives by disbursement of Association funds (through due diligence selection procedures) to individuals, institutions and specialty sub groups.

Indicators, Milestones and Benchmarks

The trustees monitor a range of measures by which to try to determine the success of the charity in meeting its objectives. These measures include:

Level of membership and the trend over time (increasing or decreasing);
Circulation and readership of BJOMS;
Level of submission of research papers for publication in BJOMS;
Requests for publications including abstracts and papers, subscriptions and proceeds of electronic downloads from BJOMS;
Attendance at the ASM;
Feedback from delegates attending the ASM;
Uptake on new initiatives to encourage ASM attendance;
Number of visits to the Association’s website and feedback from visitors;
Members’ engagement with sub specialist interest groups (SSIGs); and
Media interest/requests for information or comment to printed or electronic media.

Public Benefit

The trustees have taken the Charity Commission’s general guidance on public benefit (contained within the revised guidance publication “Charities and Public Benefit”) into consideration in preparing their statements on public benefit contained within this trustees’ annual report.

Benefits and Beneficiaries

In accordance with its charitable objectives, the Association strives to promote education, study, research and development of Oral and Maxillofacial Surgery. In doing so, BAOMS seeks to improve the quality of medical care for the benefit of patients. The charity’s ultimate beneficiaries are therefore patients, and benefits to patients are provided through advancing knowledge of, practice in and standards for the specialty.

- 10 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

OBJECTIVES AND ACTIVITIES (continued)

Public Benefit (continued)

Trustees’ Assessment of Public Benefit

In relation to the assessment of public benefit, the trustees monitor the public benefits which are delivered through the training and support of Oral and Maxillofacial Surgeons (OMFS) within the NHS and interface with individual hospital units. The Association is represented on a number of committees (see pages 11 and 12) to ensure that there are a sufficient number of OMFS consultants to serve the public need.

There is also a direct interface with the public via the Association’s website which includes advice leaflets and information about the specialty, information on NHS hospital units and also careers advice.

Grant Making Policy

The Association finances a number of awards to support education and research. These are as follows:

Down Surgical Prize Norman Rowe Lecture Prize BAOMS Surgery Prize Norman Rowe Clinical Prize Paul Toller Research Prize Junior Trainees and Members’ Prize Associate Fellows Prize Clinical and Research Poster Prizes IMP Technicians Lecture Prize Trainers’ Prizes BJOMS Prizes

The Endowments Sub-Committee (which is appointed by and from Council) meets twice a year to consider applications for research and clinical placement grants. The sub-committee recommends candidates for prizes and grants to Council and advises on the distribution of available funds.

There are prizes available to all categories of membership. Full information on the application process can be found on the BAOMS website (www.baoms.org.uk).

In addition, the Association offers student bursaries to second degree students (studying for their BDS or MBBS) who are interested in pursuing a career in Oral and Maxillofacial Surgery, together with complimentary membership of the Association where applicable and subsidised attendance fees for the Annual Scientific Meeting. Free membership and subsidised attendance rates at the ASM are also now available to first degree students with an interest in the specialty.

- 11 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

OBJECTIVES AND ACTIVITIES (continued)

Research and Travel Grants

Grants are made available to suitable and successful applicants in respect of: Significant Research Grants Major Travel Grant Trainees Travel / Study Grants Support for Specialty Meetings Small Project Grants (priming simple research projects and also mini travel grants) Student Bursaries and Student Electives

Application details are available on the Association’s website at www.baoms.org.uk

Representation on Other Bodies

The specialty of Oral and Maxillofacial Surgery is represented on the following:

British Association of Surgical Oncology (BASO) Confidential Reporting System in Surgery (CORESS) Federation of Surgical Specialist Associations (FSSA) The Royal College of Surgeons (RCS) of England Council Specialty Advisory Committee (SAC) in Oral and Maxillofacial Surgery Specialty Advisory Committee (SAC) in Oral Surgery Senate of Dental Specialties Intercollegiate Board: (FRCS) RCS Trauma Committee RCS Cancer Services Committee RCS Revalidation Board Royal College of Surgeons of Edinburgh Board European Association of Cranio and Maxillo Facial Surgeons (EACMFS) Council European Reference Network for rare diseases UEMS Monospecialty Section in Stomatology and Oral and Maxillofacial Surgery International Association of Oral and Maxillofacial Surgeons (IAOMS) BMA: CCSC Surgical Specialties Sub-Committee Department of Health Professional Bodies

The Chair of Council represents the Association at the majority of the meetings of the organisations outlined above. If the Chair of Council (or Deputy Chair) is unable to attend, where possible, an alternative representative is selected from current Council members. Reports are provided to Council following each meeting. It is vital to have a working relationship on these professional bodies to achieve the overall aims of the Association at local, national and international level.

- 12 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE

Activities, Events and their Impact

The Association has been active in a number of areas:

BAOMS Journals: BJOMS and ADOMS

BJOMS: The Association continued to organise the publication of The British Journal of Oral and Maxillofacial Surgeons (“BJOMS”), which is the official publication of the Association, through the editorial team. Members are encouraged to submit articles on Oral and Maxillofacial Surgery for publication in BJOMS. The Journal Editorial Board is managed by the Editor and the Honorary Treasurer and meets several times a year. The Editor prepares a report for each Council meeting and for the Annual General Meeting. BJOMS (10 issues per year) is currently published in conjunction with Elsevier on a five-year contract. Following a review and process carried out by the Editor and reported at a Council meeting the current publishers, Elsevier, were reappointed and a new five-year contract (2023 to 2027) was agreed and signed. Professor Panos Kyzas took over the role of Editor as planned on 1 January 2024 with a term of office (currently a five-year term).

Since 2020 and as one of the strategic aims of the Association, a second journal, “Advances in Oral and Maxillofacial Surgery” (ADOMS) was launched. This is an open access journal dedicated to publishing research articles on all aspects of surgery in the oro-facial and head and neck region. The ADOMS continues to publish original research, review articles, editorials, technical notes and case reports thus helping to create access for Junior Trainees wishing to publish, whilst maintaining the impact factor for BJOMS.

Both BJOMS and the sister Journal ADOMS continue to function well. Professor Kyzas together with his deputy Mr Rabin Singh and the whole editorial team are to be congratulated for their delivery of both journals on behalf of BAOMS.

Report from BAOMS Quality and Outcomes in Oral and Maxillofacial Surgery (QOMS) Dr Fabien Puglia, QOMS Project Manager

Twenty-eight hospitals across England, Wales and Scotland have contributed to the various registries in QOMS, to these must be added several other hospitals who are collecting data remotely and need to submit it. The project’s growth seen in 2024 was due in part to the project being added to the NHS Quality Account List for 2024-2025. Overall, we have now collected over 13,500 patient episodes of treatment in REDCap across our 6 core audits. This would not be possible without all the data coordinators and surgeons participating to the project. Thank you all.

2024 marks also two big changes for QOMS. First, most of the BAOMS -funded sites are transitioning to a new working model as their funding ran out. Most have decided to continue contributing to QOMS and several have successfully obtained local funding to keep having a data coordinator. The second big change is that Mr Michael Ho who has been leading the project since 2021 has demitted at the end of 2024. Mr David Tighe has taken a new Clinical Lead.

David has strong ambitions for the project and wants to establish it as a must-do for the specialty. David is joined at the helm of the project by two new Deputies, Ms Elizabeth Yeung (London) and Mr Samuel Kent (Fife).

- 13 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE (continued)

Activities, Events and their Impact (continued)

Reporting outcomes remains at the forefront of the project. We are planning to publish our second report in the first quarter of 2025. This report will cover the whole data collection period (2021 to 08/07/2024). With more data available, we should be able to provide more robust comparative data for outcomes for the Oncology, Reconstruction and Non-Melanoma Skin Cancers registries. We would like to take this opportunity to remind our contributors that their data can be accessed online via the series of live dashboards we have developed. Do not hesitate to contact us, if you have any questions.

ACTIVE REGSITRIES IN QOMS

The set of core audits has undergone some changes:

The Oral and Dentialveolar workstream will close in March 2025 with no plans so far to continue data collection.
A new TMJ workstream has gone live in December 2024. The TMJ SSIG Leads and Deputy Lead have developed two audits for TMJ Arthroscopy and TMJ replacement.
The other workstreams remains active: Trauma, Non-Melanoma Skin Cancers, Oncology & Reconstruction and Orthognathic Surgery

The other registries part of the QOMS project include:

The Salivary Gland Cancers registry
The Rare and benign Lesions of the Jaws registry
The BAOMS BOS Orthognathic PROM registry in collaboration with BOS
The Restorative Dentistry / Orl Rehabilitation registry in collaboration with Restorative Dentist colleagues.

Those four registries are consented.

The Patient-specific implant for mandible reconstruction registry

Participation to QOMS is open to every OMFS department in the UK. Engagement welcomed from all OMFS units and the level of contribution can be tailored to the scope of each unit’s practice.

Please contact us for more information: baomsprojectmanager@baoms.org.uk

BAOMS QOMS Executive Team: Clinical Lead: Mr David Tighe, Deputy Clinical Leads: Ms Elizabeth Yeung and Mr Samuel Kent, Project Manager: Dr Fabien Puglia. Find out more about QOMS in our newly updated webpages.

BAOMS Website: www.baoms.org.uk

The website continues to provide a useful resource for the public with online patient advice information and a facility to search for oral and maxillofacial surgeons by special interest. There are various discussion forums for BAOMS members, which are hosted in the members’ secure area.

- 14 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE (continued)

The Flex Facs online educational resource project continues to be available and on the site.

BAOMS Office and membership support

The BAOMS office team continue to work in the BAOMS office at the Royal College of Surgeons of England as well as from home. Supporting the membership with frequent website updates as well as assisting with general membership queries. The day the day to day running and management of the Association is under the direction of the Senior Administrator and Chair of Council.

Presidential Annual Fund

In 2024 /5 the 63[rd] Presidential Initiative focuses on creating a platform to assess the psychological impact of oral and maxillofacial trauma. Facial trauma not only causes physical disfigurement but also psychological distress that can impede recovery. Oral and maxillofacial surgeons are in a unique position to identify patients at risk of psychological distress and intervene early. By providing access to validated screening tools across the UK BAOMS can facilitate early detection of psychological conditions and provide pathways for onward care.

Online Book Dental Students, led Ms Nabeela Ahmed, Council member

Following on from the success of the online Book “Oral and Maxillofacial Surgery – An Illustrated Guide for Medical Students and Allied Healthcare Professionals”, the Dental Healthcare Professionals was developed during 2023 and was successfully launched in 2024.

BAOMS 2024 Annual Scientific Meeting (ASM) and other meetings Report of the 2024 BAOMS ASM, 3-5 July 2024, Hosted by 62[nd] BAOMS President, Miss Daljit K Dhariwal

The BAOMS ASM 2024 was held in Oxford at the Mathematical Institute with a theme of The Patients’ Voice. During the meeting, the BAOMS AGM and Awards Ceremony took place on Wednesday 3 July and the Presidential handover took place on Friday 5 July at the end of the conference.

The main scientific programme included Dr Liz O’Riordan, who presented the President’s Lecture entitled: Once upon a time . The Norman Rowe Lecture was delivered by Dr Daniel Borsuk entitled: The Surgical Blueprint to a Beautiful Face. There were a variety of themed sessions over the three days which included patients participating on the lecture panels. In addition there was an SAS Associate Fellows study day, an IMPT Study Day and an OMFS Nurses Study Day. There were 106 free papers which ran in parallel to the keynotes and symposia over all three days and there were also 150 ePoster abstracts. The Top 30 posters were on display on site during the meeting.

There was a welcome reception on Wednesday 3 July at the Oxford Natural History Museum with drinks and canapes around the exhibits. The Annual Dinner, on Thursday 4 July was held at the Weston Library in the Oxford City Centre with a Bollywood violinist and disco to follow the Dinner.

KLS Martin were the Platinum/main event sponsors with DePuy Synthes and Stryker as Gold sponsors along with other exhibiting companies. BAOMS are very grateful for their support. There was also a conference app

- 15 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE (continued)

which was well received. Total overall onsite attendance in 2024 was around 700 over the three-day event and feedback has been positive.

BAOMS members can also watch the keynote lectures over the three-day meeting via the Flex Facs area of the website here: https://www.baoms.org.uk/members/baoms_asm_content_to_view_.aspx noting that BAOMS members will need to login to members’ area to access. A freelance PR Professional, attended onsite to produce news items featuring the keynote speakers and other news items (see news on website) Finally, please also view the event videos filmed on site in Oxford during the meeting

BAOMS ASM 2024 Event video: (2.36)
BAOMS ASM Careers video: (3.38)
BAOMS ASM Three words video: (0.30)

Report of the 2024 Junior Trainees Conference held in Manchester 23/24 November 2024 Miss Mairead Kelly, 2024 Junior Trainee Group (JTG)

The JTG Annual Conference was held in the Science and Industry Museum, Manchester on 23[rd] and 24[th] November 2024. The conference aimed to provide delegates with knowledge and skills in OMFS, enhance clinical practice and care amongst junior trainees, foster professional development amongst our junior trainee members, and inspire the future generation of OMF surgeons by showcasing what OMFS has to offer.

The conference was organised by the JTG committee and was kindly supported by BAOMS both financially by a contribution of £5,000, and by BAOMS attending the conference and hosting a stand in the trade fair. The JTG would like to thank BAOMS for their continued annual support of the conference – the funding was used to directly lower the cost for trainees, to ensure that cost minimised as a barrier to junior trainee attendance.

The conference programme comprised keynote speakers from the breadth of OMFS, showcasing how unique and exciting our speciality is. For full details of the conference programme, please see the conference section of our website, www.jtgonline.org.

Our Gala Dinner was held on 23[rd] November at the Revolution Gallery in Manchester. The evening events included a 3-course meal, a céilí event with Irish dancers led by Gypsy Darling, and disco thereafter. A charity raffle was held in aid of CLAPA.

Although final numbers are pending, the conference was attended by between 145-155 attendees across the two days. Feedback showed that nearly 55% of attendees presented either a poster or an oral presentation. The delegates ranged first degree dental/medical students (11%), second degree students (19.5%), singly qualified medics (16.5%), singly qualified dentists (25%), and dual qualified FY1/FY2/CST1-2/ST1-2 (10.6%). The feedback to date has been overwhelmingly positive, with attendees reporting that they felt the conference was beneficial to their professional development, relevant to them and good value for money.

The JTG committee would like to thank BAOMS council for their continued support of the JTG conference, and of the JTG overall, which is growing in numbers year on year.

==> picture [457 x 38] intentionally omitted <==

- 16 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACTIVITIES, EVENTS AND THEIR IMACT (continued)

Fellows in Training update from Mr Adam Holden and Mr Amit Dattani

UK Maxillofacial Surgery Fellows in Training Conference on 9 May 2025 in Leeds City Centre

DoubleTree Hilton Organised by: Timothy Austin and the BAOMS Fellows in Training

Although there was not a conference in 2024 there are plans for one on Friday 9 May 2025 in Leeds.

Report from Consultants’ and Specialists Study Day 12 December 2024 at the Academy of Medical Sciences, London Mr Suresh Shetty, Chair of CSG and Mr David Keith, Deputy Chair of CSG

With the aim and theme of ‘Current Trends in Oral and Maxillofacial Surgery’ the programme included presentations from Professor Mark McGurk on Salivary Gland Surgery: 3 D modelling in parotid surgery and Mr Jag Dhanda on Robotics and Augmented Reality. Marilyn Howe from the Royal College of Surgeons of England also gave a presentation on Cosmetic Surgery Certification - Future events.

The meeting was well attended with over 50 BAOMS Fellows in Training and BAOMS Fellows. Many thanks to Suresh and David for organising the meeting programme and congratulations to Elizabeth Gruber who takes over the Chair of CSG role on 1st January 2025.

FlexFacs Achievements in 2024 and Transition to a Unified Educational Programme

Overview : Mr Montey Garg, National Online Training Programme Director

2024 has been a transformative year for FlexFacs, marking its transition to a more integrated educational initiative under NHS England. These developments ensure continued access to high-quality, centralised learning resources for OMFS professionals while maintaining strong support for BAOMS members.

A Unified Educational Initiative

Since its launch in September 2021, the BAOMS-led FlexFacs programme has played a pivotal role in fostering collaboration, professional development, and knowledge-sharing for OMFS trainees and members.

In 2024, NHS England launched a national programme unifying surgical education across all specialties via the Postgraduate Virtual Learning Environment (PGVLE). FlexFacs has been recognised as a model of excellence in postgraduate education, with its success highlighted during NHS England’s national surgical training programme meetings in Birmingham. At this meeting, Mr Montey Garg, serving as the National Online Training Programme Director for OMFS, represented the programme and its achievements.

As of June 2024, FlexFacs transitioned to NHS England’s management. Following collaborative discussions led by Mr Garg with the NHS Lead for national programmes, it was agreed that FlexFacs would continue to serve BAOMS members alongside trainees. Provisions were also made to allow BAOMS to upload relevant content to its own website, ensuring members retain access to the programme at no cost to the association.

2024 Highlights

Engaging Online Sessions: Monthly webinars featuring dynamic discussions and broad participation.
Informative Newsletters: Pre-session newsletters introduced to provide journal links for better preparation and engagement.
Quiz Day Success: The March 2024 OMFS Quiz Day saw outstanding participation, with three topperforming trainees recognised.
Enhanced CPD for Members: In November 2024, free verifiable CPD credits were introduced for BAOMS members by Mr Garg, reinforcing the programme’s commitment to professional development

Looking Ahead

As FlexFacs continues under NHS England’s management, it remains a benchmark for unified, high-quality

- 17 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

surgical education. FlexFacs stands as a testament to the strength of collaboration, offering robust support for OMFS trainees and BAOMS members alike.

FINANCIAL REVIEW

Financial Results of Activities and Events

During 2024, the Association generated £844,803,(2023: £1,205,285) of income, and expended resources of £1,028,234,(2023: £950,053) principally disseminating information as it relates to any and all of the fields that pertain to the Association’s charitable objectives.

In particular, 2024 Annual Scientific Meeting resulted in a surplus of £62,166, (2023: deficit of £3,197) and the British Journal of Oral and Maxillofacial Surgery plus the Advances in Oral and Maxillofacial Surgery contributed a surplus of £150,535, (2023: £171,815). A significant proportion of Journal income arose from paid electronic downloads of content – from around the globe, demonstrating the breadth of appeal of the material presented. Net investment gains in the year were £71,605, (2023: gains £33,999). Overall, there was a net decrease in funds of £111,826, (2023: increase £289,051).

Grant Making

In 2024, grants totalling £135,728, (2023: £42,856) were allocated during the financial year to members of the Association for research projects and travel to centres of excellence overseas.

The Association continues to support bursaries for medical students completing their double degree as part of the relatively long training programme for the specialty. In 2024, £33,500 was awarded to thirty six individuals (2023: £34,250 was awarded to thirty one individuals).

Reserves Policy

When considering the need for free reserves the trustees are mindful that they must put in place a suitable foundation for the charity to achieve its long-term strategic goal, that being for the work of the Association to be continued in perpetuity. In addition, the trustees have identified the following areas in which expenditure will be required soon:

In addition to the day-to-day work of the Association the following and on-going areas have been identified in 2024:

Up to £12,500 for the speakers’ educational fund to fund educational lectures at the Annual Meeting

£100,000 for research and clinical / mini grants;

£15,000 to provide complimentary membership of the Association to students studying their second degree;

£10,000 to provide complimentary registration at the ASM for students studying for their first and second degrees;

£30,000 (up to £40,000) to provide student bursaries/support to students studying their second degree;

- 18 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

FINANCIAL REVIEW (continued)

£15,000 to support the junior trainees programme, ASiT membership and recruitment

£15,000 venue deposits for future meetings;

£10,000 for updates to the website on-going

£5,000 for on-going hosting (£1,000 pcm), support and development of the website (Light Media) to continue to increase its educational and interactive capacity and to further widen communication with the membership;

£10,000 support costs for membership application system (Oomi)

£25,000 for the President’s Annual Fund

£75,000 QOMS Project manager and audit registry

Reserves Policy

Bearing this in mind the trustees consider that, in order to limit financial risk and based on current staffing levels, the level of free reserves should be equal to £500,000. This will allow the capacity to operate the work of the Association effectively in the event of unforeseen financial difficulties. It is expected that this would be sufficient to cover the operational costs of the Association for a period of nine months.

Financial Position

The total ‘unrestricted funds’ of the charity as at 31 December 2024 amounted to £1,231,265, of which £398,980 had been allocated to the Designated Research Fund (31 December 2023: £1,362,294 of which £823,262 had been allocated to the Designated Research Fund) and £7,032 (2023: £14,064) relates to the remaining net book value of fixed assets, and therefore do not form part of the free reserves. The free reserves of the charity as of 31 December 2024 therefore amounted to £825,253 (2023: £539,032) and include a £500,000 transfer from the designated research fund.

In 2024, the Charity About Face transferred funds to BAOMS to be managed as a restricted grant named “Ilankovan About Face Grant", in such amount(s) to be decided by the Endowment sub-committee of BAOMS, to be awarded to Fellows/ Members of BAOMS in order to support Head & Neck Cancer research projects, subject to suitable applications being received. Although the funds were transferred and received by BAOMS in 2024, they met the criteria for income recognition in 2023 and as such were accrued at 31 December 2023.

Designated Research Fund following the Trustees’ decision to release designated funds that were held surplus to requirements.

Investments Policy

The trustees have wide ranging powers to invest the funds of the Association as they see fit, and in practice, they receive advice from the Association’s investment managers on appropriate investments. The Association’s investment portfolio is now managed by Cazenove Capital Management wealth management from Schroders.

BAOMS uses a Responsible Multi-Asset Fund which has no direct exposure to Russia through any of its investments.

Alongside its financial aims, the Fund has an explicit responsible investment policy, screening out areas of concern to many charities, integrating environmental, social and governance analysis as a fundamental part of its

- 19 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

FINANCIAL REVIEW (continued)

equity selection process and promoting best practice through active engagement. The managers invest to avoid harm, benefit society through responsible business activities and contribute to solutions through investing for impact. The investment managers will also use their influence to push for progress towards the Sustainable Development Goals.

Whilst there is no specific screen within the mandate to exclude Russian investments, given the fund’s overall aims, no Russian stocks were deemed appropriate for the strategy and in-line with the Responsible policy.

Investment Strategy

The investment objective is to be achieved by investment in a balanced portfolio, which can include equities, fixed interest securities and cash, with a medium risk profile. Exposure to hedge funds, structured investments and property funds will also be permissible. Trustees have taken advice and rely on an approach to provide real returns on funds , but avoiding High Risk / High Yield (Casino) patterns of investment, in line with responsible charitable organisation strategy.

Investments Policy

Review

In order to monitor progress of the performance of the Association’s investments against this policy Cazenove Capital Management wealth management from Schroders provides valuation reports six monthly on 30 June and 31 December. Figures showing the capital performance and a range of indices including the APCIMS Balanced Index are included within these valuation reports.

The trustees will periodically consider whether there is a need to revise the Investment Strategy.

In 2024, the portfolio increased in value by 16% to £1,615,085, (2023: increased 2.5% to £1,386,998). The income being generated by the investments increased by 17% to £85,337 (2023: 4.6% to £72,937) and is derived from a combination of exposure to high yielding equities as well as the fixed interest area of the market.

- 20 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

PLANS FOR FUTURE PERIODS

BAOMS Annual Scientific Meeting (ASM) 18-20June 2025 Hosted by BAOMS 63[rd] President Professor Kathleen Fan

BAOMS 2025 Annual Scientific Meeting will be held at the historic Guildhall in London from 18-20 June 2025. The theme of the meeting is global practice. There will be colleagues joining the conference from around the world to share knowledge, exchange ideas, practice and innovations to improve overall patient outcome.

Global health inequalities will be showcased in the humanitarian section, with surgeons sharing their experience in underserved regions.

The welcome reception will be the Guildhall Art Gallery and the Gala dinner in the magnificent Guildhall Great Hall.

There will be three parallel sessions running throughout the conference, including a session dedicated to SAS surgeons, OMFS nurses and Industry supported sessions.

These financial statements were approved by the members of the Trustees committee on 19 March 2025 and are signed on their behalf by:

aa President Professor Kathleen Fan

Ph Honorary Treasurer Mr Shaukat Mahmood

- 21 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2024

Opinion

We have audited the financial statements of The British Association of Oral and Maxillofacial Surgeons (the ‘charitable company’) for the year ended 31 December 2024 which comprise the statement of financial activities, the balance sheet, and statements of cash flows, the principal accounting policies and the notes to the financial statements. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

♦ give a true and fair view of the state of the charitable company’s affairs as at 31 December 2024 and of its income and expenditure for the year then ended;
♦ have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
♦ have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

- 22 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2024

Other information (continued)

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

♦ the information given in the trustees’ report which is also the directors’ report for the purposes of company law, for the financial year for which the financial statements are prepared is consistent with the financial statements; and
♦ the trustees’ report, which is also the directors’ report for the purposes of company law, has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

♦ adequate accounting records have not been kept; or
♦ the financial statements are not in agreement with the accounting records and returns; or
♦ certain disclosures of trustees’ remuneration specified by law are not made; or
♦ we have not received all the information and explanations we require for our audit; or
♦ the trustees were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies’ exemptions in preparing the trustees’ report and from the requirement to prepare a strategic report.

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

- 23 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2024

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

♦ The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
♦ We obtained an understanding of the legal and regulatory frameworks that are applicable to the charity and determined that the most significant frameworks which are directly relevant to specific assertions in the financial statements, being the Charities Act 2011, Companies Act 2006, health and safety legislation, the data protection act, and the reporting framework as detailed within the accounting policies;
♦ We focused on specific laws and regulations which we considered may have a direct material effect on the accounts.
♦ We assessed the extent of compliance with the laws and regulations identified above through making enquiries of representatives of management and the review of minutes of Trustee meetings.

We assessed the susceptibility of the charity’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

♦ Making enquiries of where management considers there was susceptibility to fraud and knowledge of actual, suspected and alleged fraud; and
♦ Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

♦ Performed analytical procedures to identify any unusual or unexpected relationships;
♦ Tested and reviewed journal entries to identify unusual transactions;
♦ Tested the authorisation of expenditure;
♦ Gained an understanding of the processes in place for the management of the charity’s investments and confirmed the validity of withdrawals from investments; and
♦ Investigated the rationale behind significant or unusual transactions.

- 24 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

YEAR ENDED 31 DECEMBER 2024

Auditor’s responsibilities for the audit of the financial statements (continued)

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

♦ Review of the minutes of meetings of those charged with governance;
♦ Enquiring of management as to actual and potential litigation and claims; and
♦ Agreeing accounts disclosures to underlying supporting documentation.

As a result of our procedures we did not identify any key audit matters relating to irregularities.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the trustees and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of this report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Catherine Biscoe Senior Statutory Auditor For and on behalf of Buzzacott LLP Statutory Auditor 130 Wood Street London EC2V 6DL

- 25 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING THE INCOME AND EXPENDITURE ACCOUNT)

YEAR ENDED 31 DECEMBER 2024

		Unrestricted	Restricted	Total	Total
		Funds	Funds	Funds 2024	Funds 2023
		£	£	£	£
	Note
INCOME FROM
Donations	16	-	-	-	397,965
Investments	2	74,037	12,059	86,096	72,937
Charitable activities	3	758,707	-	758,707	734,383
		--------------------------------------	------------------------------------	------------------------------------	------------------------------------
TOTAL INCOME		832,744	12,059	844,803	1,202,285
		---------------------------------------	-----------------------------------	------------------------------------	------------------------------------
EXPENDITURE ON
Raising Funds
Investments	4	13,345	3,543	16,888	12,433
Charitable activities		1002,445	8,901	1,011,346	937,800
		-------------------------------------	---------------------------------	------------------------------------	------------------------------------
TOTAL EXPENDITURE		1,015,790	12,445	1,028,234	950,233
		--------------------------------------	------------------------------	------------------------------------	------------------------------------
NET (EXPENDITURE)
INCOME FOR THE
YEAR BEFORE GAINS,
ON INVESTMENTS		(183,046)	(386)	(183,432)	255,052
Net gains on investments	12	52,017	19,588	71,605	33,999
		-------------------------------------------	------------------------------------------	----------------------------------	----------------------------------
NET (EXPENDITURE)
INCOME FOR THE YEAR
AND NET MOVEMENT IN
FUNDS		(131,029)	19,202	(111,826)	289,051
RECONCILIATION OF
FUNDS
Total funds brought forward		1,362,294	502,954	1,865,248	1,576,197
		-----------------------------------------------	------------------------------------	-----------------------------------------------	-----------------------------------------------
TOTAL FUNDS CARRIED
FORWARD		1,231,265	522,156	1,753,421	1,865,248
		===============================================	====================================	===============================================	===============================================

All recognised gains and losses are included in the above statement of financial activities. All of the above amounts relate to continuing activities.

The notes on pages 28-43 form part of these financial statements

- 26 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

COMPARATIVE STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2023

		Unrestricted	Restricted	Total	Total
		Funds	Funds	Funds 2023	Funds 2022
		£	£	£	£
	Note
INCOME FROM
Donations	16	-	397,965	397,965	-
Investments	2	72,937	-	72,937	69,740
Charitable activities	3	734,383	-	734,383	793,065
		--------------------------------------	------------------------------------	------------------------------------	------------------------------------
TOTAL INCOME		807,320	397,965	1,205,285	862,805
		---------------------------------------	-----------------------------------	------------------------------------	------------------------------------
EXPENDITURE ON
Raising Funds
Investments	4	12,433	-	12,433	15,459
Charitable activities		937,620	180	937,800	927,612
		-------------------------------------	---------------------------------	------------------------------------	------------------------------------
TOTAL EXPENDITURE		950,053	180	950,233	943,071
		--------------------------------------	------------------------------	------------------------------------	------------------------------------
NET EXPENDITURE FOR
THE YEAR BEFORE
GAINS, (LOSSES)ON
INVESTMENTS		(142,733)	397,785	255,052	(80,266)
Net gains, (losses) on
investments	12	33,999	-	33,999	(154,635)
		-------------------------------------------	------------------------------------------	----------------------------------	----------------------------------
NET (EXPENDITURE) INCOME
FOR THE YEAR AND NET
MOVEMENT IN FUNDS		(108,734)	397,785	289,051	(234,901)
RECONCILIATION OF FUNDS
Total funds brought forward		1,471,028	105,169	1,576,197	1,811,098
		-----------------------------------------------	------------------------------------	-----------------------------------------------	-----------------------------------------------
TOTAL FUNDS CARRIED
FORWARD		1,362,294	502,954	1,865,248	1,576,197
		===========================================		===========================================	===========================================
		====	====================================	====	====

The notes on pages 28-43 form part of these financial statements

- 27 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

BALANCE SHEET

31 DECEMBER 2024

			2024	2023
	Note	£	£	£
FIXED ASSETS
Intangible assets	11		7,032	14,064
Tangible assets	11		-	-
Investments	12		1,615,085	1,386,998
			-----------------------------------------------	-----------------------------------------------
			1,622,117	1,401,062
CURRENT ASSETS
Debtors	13	346,711		714,191
Cash in hand		83,954		60,900
		------------------------------------		------------------------------------
		430,665		775,091
CREDITORS: Amounts falling due within one
year	14	299,361		310,905
		------------------------------------		------------------------------------
NET CURRENT ASSETS			131,304	464,186
			-----------------------------------------------	-----------------------------------------------
NET ASSETS			1,753,421	1,865,248
			===============================================	===============================================
THE FUNDS OF THE CHARITY
Restricted funds	16		522,156	502,954
Unrestricted funds: General	17		398,980	539,032
Unrestricted funds: Designated	17		832,285	823,262
			-----------------------------------------------	-----------------------------------------------
TOTAL CHARITY FUNDS			1,753,421 ===============================================	1,865,248 ===============================================

These financial statements were approved on 19 March 2025 committee and are signed on their behalf by:

and signed by the member of the

President Professor Kathleen Fan

Honorary Treasurer Mr Shaukat Mahmood

Company Registration Number: 03337359

The notes on pages 28-43 form part of these financial statements

- 28 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

STATEMENT OF CASH FLOWS

YEAR ENDED 31 DECEMBER 2024

Note CASH INFLOW/(OUTFLOW) FROM OPERATING ACTIVITIES NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 19 CASH (OUTFLOW) INFLOW FROM INVESTING ACTIVITIES Income from UK Listed Investments Purchases of Listed Investments Proceeds from disposal of Listed Investments Interest received Net cash (used in) provided by investing activities CHANGE IN CASH AND CASH EQUIVALENTS IN THE YEAR 20 CASH AND CASH EQUIVALENTS 1 JANUARY 20 CASH AND CASH EQUIVALENTS 31 DECEMBER 20	2024 £ 93,440 85,337 (406,482) 250,000 759 ----------------------------------------- ----- (70,386) ------------------------------- ----- ---- 23,054 60,900 ----------------------------------------- 83,954	2023 £ (125,063) 71,243 - - 1,694 ----------------------------------------- 72,937 ----------------------------------------- (52,126) 113,026 ______ 60,900

The notes on pages 28-43 form part of these financial statements

- 29 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

1. ACCOUNTING POLICIES

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are laid out below.

Basis of preparation

These financial statements have been prepared for the year to 31 December 2024.

The financial statements have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant accounting policies below or the notes to these financial statements.

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) (Charities SORP FRS 102) and the Companies Act 2006.

The charity constitutes a public benefit entity as defined by FRS 102.

The financial statements are presented in sterling and are rounded to the nearest pound.

Critical accounting estimates and areas of judgement

Preparation of the financial statements requires the trustees and management to make significant judgements and estimates.

The items in the financial statements where these judgements and estimates have been made include:

♦ estimating the liability for multi-year grant commitments;
♦ estimating the useful economic life of fixed assets; and
♦ estimating the BJOMS profit share based on 67.5% of profit (after expenditure) as per contract.

Assessment of going concern

The trustees have assessed whether the use of the going concern assumption is appropriate in preparing these financial statements. The trustees have made this assessment in respect to a period of one year from the date of approval of these financial statements. The trustees of the charity have concluded that, there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the charity to continue as a going concern.

- 30 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

Assessment of going concern (continued)

The Association will be running a number of well subscribed events in 2025. The Association anticipates good levels of cash in 2025 despite increases in inflation, the current economic climate and cost of living challenges.

The Trustees have reviewed the risks posed to the charity and concluded that the charity are in a strong financial and operational position and can continue to support beneficiaries now and for the foreseeable future.

The trustees are therefore of the opinion that the charity will have sufficient resources to meet its liabilities as they fall due.

With regard to the next accounting period, the year ending 31 December 2025, the most significant areas that affect the carrying value of the assets held by the charity are the level of investment return and the performance of the investment markets.

Income recognition

Income is recognised in the period in which the charity has entitlement to the income, the amount of income can be measured reliably, and it is probable that the income will be received.

Donations are recognised when the charity has confirmation of both the amount and settlement date. In the event of donations pledged but not received, the amount is accrued for where the receipt is considered probable.

Credit is taken in the statement of financial activities for the proportion of subscriptions which are receivable in the financial year. All other similar types of income are accounted for on an accruals basis.

In accordance with the Charities SORP FRS 102 volunteer time is not recognised.

Dividends are recognised once the dividend has been declared and notification of the dividend has been received.

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.

Expenditure recognition

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to make a payment to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

- 31 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

Expenditure recognition (continued)

All expenditure is accounted for on an accruals basis. Expenditure comprises direct costs and support costs. All expenses, including support costs, are allocated or apportioned to the applicable expenditure headings. The classification between activities is as follows:

Grants payable are included in the statement of financial activities when approved and when the intended recipient has either received the funds or been informed of the decision to make the grant and has satisfied all performance conditions. Grants approved but not paid at the end of the financial year are accrued. Grants where the beneficiary has not been informed or has to fulfil performance conditions before the grant is released are not accrued for.

Irrecoverable VAT is included within support costs and allocated as detailed below.

♦ Expenditure on raising funds includes all expenditure associated with raising funds for the charity. This includes investment management fees.
♦ Expenditure on charitable activities includes all costs associated with furthering the charitable purposes of the charity through the provision of its charitable activities. Such costs include grants, direct and support costs including governance costs.

Allocation of support and governance costs

Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the charity it is necessary to provide support in the form of personnel development, financial procedures, provision of office services and equipment and a suitable working environment.

Governance costs comprise the costs involving the public accountability of the charity including audit costs) and costs in respect to its compliance with regulation and good practice.

Support costs including staff costs and governance costs are apportioned based on the proportion used by the activity.

Intangible fixed assets

All assets costing more than £5,000 and with an expected useful life exceeding one year are capitalised. Amortisation is provided over a period of 5 years, based on the estimated useful life of the asset, on a straight line basis.

Tangible fixed assets

All assets costing more than £5,000 and with an expected useful life exceeding one year are capitalised.

- 32 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

Tangible fixed assets (continued)

Furniture and equipment

Expenditure on the purchase and replacement of furniture and equipment is capitalised and depreciated over a 4–10-year period, based on the estimated useful life of the asset, on a straight line basis.

Fixed asset investments

Listed investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price.

The charity does not acquire put options, derivatives or other complex financial instruments.

Realised gains (or losses) on investment assets are calculated as the difference between disposal proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. Unrealised gains and losses are calculated as the difference between the fair value at the year end and their carrying value at that date. Realised and unrealised investment gains (or losses) are combined in the statement of financial activities and are credited (or debited) in the year in which they arise.

Debtors

Debtors are recognised at their settlement amount, less any provision for non-recoverability. Prepayments are valued at the amount prepaid.

Cash at bank and in hand

Cash at bank and in hand represents such accounts and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.

Creditors and provisions

Creditors and provisions are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Creditors and provisions are recognised at the amount the charity anticipates it will pay to settle the debt.

Operating lease agreements

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profits on a straight line basis over the period of the lease.

- 33 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

Pension costs

The charitable company participates in a multi-employer defined benefit pension scheme known as Superannuation Arrangements of the University of London (''SAUL''). The scheme is contracted out of the State Earnings-Related Pension Scheme, and is a centralised scheme for certain employees with the assets held in separate trustee-administered funds. The charitable company is unable to identify its share of the underlying assets and liabilities of the scheme.

The amount charged to the statement of financial activities in respect of pension costs is the total contributions payable for the year.

Fund Structure

The general fund comprises the accumulated surpluses of unrestricted income over expenditure, which are available for use in furtherance of the general objectives of the charitable company.

Designated funds are a particular form of unrestricted funds consisting of amounts, which have been allocated or designated for specific purposes by the trustees. The use of designated funds remains at the discretion of the trustees.

Restricted funds are funds subject to specific conditions imposed by donors. The purpose and use of the funds are set out in the notes to the accounts. Amounts unspent at the year-end are carried forward in the balance sheet.

- 34 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

2. INCOME FROM INVESTMENTS

2. INCOME FROM INVESTMENTS
Unrestricted Funds Restricted Funds Total Funds 2024 £ £ £ Income from UK listed investments 73,278 12,059 85,337 Bank interest receivable 759 - 759 ------------------------------- ------------------------------- ------------------------------- 74,037 12,059 86,096 =============================== =============================== =============================== 3. INCOME FROM CHARITABLE ACTIVITIES Unrestricted Funds Restricted Funds Total Funds 2024 £ £ £ Subscription income from members 156,794 - 156,794 Journal income 301,950 - 301,950 Annual scientific meeting income 299,963 - 299,963 -------------------------------- -------------------------------- -------------------------------- 758,707 - 758,707 ========================-================ ==================================== ========================================	Unrestricted Funds
	Total Funds 2023 £ 71,243 1,694 ------------------------------- 72,937 =============================== Total Funds 2023 £ 167,754 330,676 235,953 -------------------------------- 734,383 ========================================

2.
INCOME FROM INVESTMENTS

Unrestricted
Funds
Restricted
Funds
Total Funds
2024
£
£
£
Income from UK listed investments
73,278
12,059
85,337
Bank interest receivable
759
-
759
-------------------------------
-------------------------------
-------------------------------
74,037
12,059
86,096
===============================
===============================
===============================
3.
INCOME FROM CHARITABLE ACTIVITIES
Unrestricted
Funds
Restricted
Funds
Total
Funds
2024
£
£
£
Subscription income from members
156,794
-
156,794
Journal income
301,950
-
301,950
Annual scientific meeting income
299,963
-
299,963
--------------------------------
--------------------------------
--------------------------------
758,707
-
758,707
========================-================
====================================
========================================

Unrestricted
Funds

Total Funds
2023
£

71,243

1,694
-------------------------------

72,937
===============================
Total
Funds
2023
£
167,754
330,676
235,953
--------------------------------
734,383
========================================

During the year ended 31 December 2024 the Annual Scientific Meeting generated a surplus of £62,166, (income £299,963). During the year ended 31 December 2023 the Annual Scientific Meeting recorded a deficit of £3,197 (income £235,953) due to the recognition of sunk costs on deferral of the event.

eferral of the event.
	Unrestricted	Restricted	Total Funds
	Funds	Funds	2023
	£	£	£
Subscription income from members	167,754	-	167,754
Journal income	330,676	-	330,676
Annual scientific meeting income	235,953	-	235,953
	--------------------------------	--------------------------------	--------------------------------
	734,383	-	734,383
	========================-===	====================================	========================================

- 35 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

4. INVESTMENT MANAGEMENT COSTS

==> picture [430 x 86] intentionally omitted <==

----- Start of picture text -----
|||||| |---|---|---|---|---| |Unrestricted| |Funds| |Unrestricted|Restricted|Total Funds|Total Funds| |Funds|Funds|2024|2023| |£|£|£|£| |-------------------------------|-------------------------------|-------------------------------|-------------------------------| |Investment management fees|13,345|3,543|16,888|12,433| |===============================|===============================|===============================|===============================|

----- End of picture text -----

5. EXPENDITURE ON CHARITABLE ACTIVITIES

==> picture [432 x 238] intentionally omitted <==

----- Start of picture text -----
|||||| |---|---|---|---|---| |Unrestricted|Restricted|Total Funds|Total Funds| |Funds|Funds|2024|2023| |£|£|£|£| |Grants awarded (note 7)|135,728|-|135,728|42,856| |Costs of disseminating information| |on the speciality|608,777|8,901|617,678|675,963| |Support costs (note 6)|257,940|-|257,940|218,981| |-----------------------------------|---------------------------------|--------------------------------------|--------------------------------------| |1,002,445|8,901|1,011,346|937,800| |========================================|=======================================|====================================|====================================| |Unrestricted|Restricted|Total Funds| |Funds|Funds|2023| |£|£|£| |Grants awarded (note 7)|42,856|-|42,856| |Costs of disseminating information| |on the speciality|675,783|180|675,963| |Support costs (note 6)|218,981|-|218,981| |-----------------------------------|---------------------------------|--------------------------------------| |937,620|180|937,800| |====================================== ==================================== ====================================|

----- End of picture text -----

6. SUPPORT COSTS

==> picture [430 x 174] intentionally omitted <==

----- Start of picture text -----
|||| |---|---|---| |Unrestricted Funds| |Total Funds|Total Funds| |2024|2023| |£|£| |Salaries and wages|143,184|130,290| |Communications costs|1,232|3,048| |Audit fees|11,500|10,250| |Rent and rates|17,131|13,999| |Bookkeeping|14,860|11,515| |Finance costs|11,511|9,161| |Irrecoverable VAT expense|51,224|35,118| |Other office costs|7,298|5,600| |------------------------------------|------------------------------------| |257,940|218,981| |=====================-===============|=====================-===============|

----- End of picture text -----

- 36 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

7. ANALYSIS OF GRANTS

ANALYSIS OF GRANTS
	2024	2023
	£	£
Grants to individuals
Research grants awarded to six individuals (2023: one)	79,995	3,710
Travel electives and mini grants awarded to fourteen individuals.
(2023: twenty five)	11,532	13,870
Student bursaries awarded to thirty six individuals (2023: thirty-
one)	33,500	34,250
Poster prizes awarded to three individuals (2023: five)	600	900
Prizes to members
President's prize awarded to two individuals (2023:two)	1,000	1,000
Norman Rowe clinical prize to one individual (2023: one)	500	500
Paul Toller research prize to one individual,(2023:one)	500	500
BAOMS surgery prize to one individual,(2023:ne)	700	700
BAOMS members prize awarded to one individual (2023: one)	500	500
Down surgical prize awarded to two individuals (2023: one)	2,000	1,000
Trainer of the year awarded to one individual (2023: one)	250	250
Associate fellows prize awarded to one individual (2023: one)	500	500
Returned or cancelled awards	(10,075)	(23,000)
	------------------------------	------------------------------
	121,602	34,680
Speakers educational fund expenditure	14,126	8,176
	------------------------------	------------------------------
Total grants	135,728	42,856
	===============================	====================================

8. NET (EXPENDITURE)/INCOME FOR THE YEAR BEFORE GAINS ON INVESTMENTS

This is stated after charging:

	2024	2023
	£	£
Staff costs (note 9)	143,184	130,290
Auditors’ remuneration	11,500	10,250
Operating lease rentals	15,759	13,999
Depreciation/amortisation	7,032	7,032
	===============================	===============================

- 37 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

9. STAFF COSTS, TRUSTEES EXPENSES AND REMUNERATION OF KEY MANAGEMENT PERSONNEL

Total staff costs were as follows:

	2024	2023
	£	£
Wages and salaries	112,372	102,350
Social security costs	7,997	6,552
Other pension costs	22,815	21,388
	-------------------------------------	-------------------------------------
	143,184 ====================================	130,290 ====================================

The key management personnel of the charity in charge of controlling, running and operating the charity on a day to day basis comprise the trustees, the Chairman of the Council and the Senior Administrator.

The total remuneration (including taxable benefits and pension contributions) paid to key management personnel for the year was £101,020 (2023: £93,427).

One Officer of the Council received £39,114 (2023: one Officer: £28,429) for services as Council members provided to the Association. No trustees received any remuneration for their services as trustees. During the year, Council members were reimbursed for travel expenses incurred in attending Council and other relevant meetings totalling £10,069 (2023: £24,453), of which four (2023: five) trustees received £4,476 (2023: £18,060).

The charity has taken out a public liability insurance policy that provides professional indemnity cover (amounting to £500,000 in respect of any one claim) for the Council members (including the trustees) and staff of the charity. The cost of this insurance policy to the charity for the year was £1,201 (2023: £1,548).

Particulars of employees:

The average number of employees during the year:

Particulars of employees: The average number of employees during the year:
	2024	2023
	No.	No.
Office and administration staff	2	2
	--------------	--------------
	2	2
	-===============	================

One employee earned remuneration of more than £70,000 and less than £80,000 (including taxable benefits but excluding employer’s pension contributions) during the year (2023: one).

10. TAXATION

The British Association of Oral Maxillofacial Surgeons is a registered charity and therefore is not liable to income tax or corporation tax on income or gains derived from its charitable activities, as they fall within the various exemptions available to registered charities.

- 38 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

11. FIXED ASSETS
Intangible
assets
Office
equipment
£
£
COST
At 1 January 2024
35,160
8,261
------ ----------------------
----------------------------
At 31 December 2024
35,160
8,261
==========================
===============================
DEPRECIATION AND AMORTISATION
At 1 January 2024
7,032
8,261
Charge for the year
7,032
-
--------------------------
--------------------------
At 31 December 2024
14,064
8,261
==========================
==========================
NET BOOK VALUE
At 31 December 2024
7,032
-
==========================
==========================
At 31 December 2023
14,064
-
==========================
==========================
12. INVESTMENTS
Movement in market value
Market value at 1 January
Additions
Disposals (Proceeds £250,000, loss of £38,424)
Net unrealised gains
Market value at 31 December
=
Historical cost at 31 December

Quoted investments
Alternative (UK)

Computer
equipment
Total
£
£
16,019
59,440
--------------------------------
--------------------------------
16,019
59,440
===============================
===============================
16,019
45,376
-
7,032
-------------------------------
-------------------------------
16,019
52,408
===============================
===============================
7,032
==========================
==========================
-
14,064
==========================
===============================
2024
2023
£
£
1,386,998
1,352,999
406,482
-
(288,424)
-
110,029
33,999
-----------------------------------------------
-----------------------------------------------
1,615,085
1,386,998
==============================================
===============================================
1,591,198
1,193,235
===============================================
====================================
2024
2023
£
£
1,615,085
1,386,998
-----------------------------------------------
-----------------------------------------------
1,6150,85
1,386,998

As at 31 December 2024 and 31 December 2023, all holdings were within Cazenove Charity Responsible Multi Asset Funds. This includes the Ilankovan About Face Fund as held in the same Cazenove Charity Responsible Multi Asset Fund under a separate account.

- 39 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

13. DEBTORS

Trade debtors
Other debtors
Prepayments
Accrued income
CREDITORS: Amounts falling due within one year
Trade creditors
Taxation and social security
Unpaid awards, grants and prizes
Accruals
Deferred income
Deferred Income
Deferred income brought forward
Income deferred in the current year
Deferred income released in the current year
Deferred income carried forward

2024
2023
£
£
23,226
76,089
15,189
-
113,069
240,137
195,227
397,965
--------------------------------------
--------------------------------------
346,711
714,191
====================================
====================================
2024
2023
£
£
13,669
3,045
4,365
8,259
105,185
53,575
66,817
82,701
109,324
163,325
------------------------------------
------------------------------------
299,360
310,905
====================================
====================================
2024
2023
£
£
163,325
81,179
109,324
82,825
(163,325)
(81,179)
109,324
163,325

14. CREDITORS: Amounts falling due within one year

Deferred income relates to subscription income and meeting income in advance.

15. COMMITMENTS UNDER OPERATING LEASES

At 31 December the charity had future minimum commitments under non-cancellable operating leases as set out below:

ases as set out below:
	Land and buildings
	2024		2023
Payments which fall due:	£		£
Within one year	21,862		13,896
Within 2 to 5 years	9,109		10,422
	----------------------------------	----------------------------------
	30,971		24,318
	-================================		===============================

- 40 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

16. RESTRICTED INCOME FUNDS

Year ended 31 December	Balance at				Balance at
2024	1 Jan 2024	Income	Expenditure	Gains	31 Dec 2024
	£	£	£	£	£
e Learning Fund	89,041	-	-	-	89,041
Norman Rowe Fund	13,123	-	8,902	-	4,221
Map of Medicine	2,825	-	-	-	2,825
Ilankovan About Face
Fund	397,965	12,059	3,543	19,558	426,069
	------------------------------------	------------------------------------	------------------------------------	------------------------------------	------------------------------------
	502,954 ====================================	12,059 ====================================	12,445 ====================================	19,558 ====================================	522,156 ====================================

The e Learning Fund was set up in 2009 following the receipt of funding from the Department of Health to cover the costs incurred by BAOMS in relation to the e Learning project as it relates to the charity's specialty.

The Norman Rowe International Educational Foundation Fund was set up in 2007 following the receipt of a donation from the Norman Rowe Educational Trust which has become a subcommittee of the charity known as the Norman Rowe International Education Foundation (NRIEF). The funds are used to promote the oral and maxillofacial specialist needs of developing and post conflict countries.

The Map of Medicine Fund was set up in 2009 to recognise specific sponsorship income contributing to the costs of the Map of Medicine project work.

The Ilankovan About Face fund was set up following the receipt of a donation from the About Face charity. The funds are managed by the BAOMS Endowments Sub Committee and used for supporting head and neck cancer research in the widest sense.

Year ended 31 December	Balance at			Balance at
2023	1 Jan 2023	Income	Expenditure	31 Dec 2023
	£	£	£	£
e Learning Fund	89,041	-	-	89,041
Norman Rowe Fund	13,303	-	(180)	13,123
Map of Medicine	2,825	-	-	2,825
Ilankovan About Face Fund	-	397,965	-	397,965
	------------------------------------	------------------------------------	------------------------------------	------------------------------------
	105,169	397,965	(180)	502,954
	====================================	====================================	====================================	====================================

- 41 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2024

17. UNRESTRICTED INCOME FUNDS

==> picture [459 x 99] intentionally omitted <==

----- Start of picture text -----
|||||||| |---|---|---|---|---|---|---| |Year ended 31|Balance at|Gains and|Balance at| |December 2024|1 Jan 2024|Income Expenditure|Transfers|losses|31 Dec 2024| |£|£|£|£|£|£| |Designated| |Research Fund|823,262|44,283|-|(500,000)|31,435|398,980| |General Funds|539,032|788,461|1,015,790|500,000|20,582|832,285| |--------------------------------------------------|---------------------------------------|--------------------------------------|--------------------------------------|---------------------------------|--------------------------------------------------| |1,362,294|832,744|1,015,790|-|52,017|1,231,265| |===============================================|====================================|====================================|====================================|===============================|===============================================|

----- End of picture text -----

The Designated Research Fund was set up by the trustees in 2005 by a transfer of £500,000 from the General Fund. These funds have been invested and will be used to provide further research and educational grants to promote wider research in the speciality. The Trustees made the decision during the year ended 31 December 2024 to release designated funds that were held surplus to requirements, and so £500,000 was transferred from the Designated Research Fund to the General Fund.

==> picture [458 x 99] intentionally omitted <==

----- Start of picture text -----
|||||||| |---|---|---|---|---|---|---| |Year ended 31|Balance at|Gains and|Balance at| |December 2023|1 Jan 2023|Income|Expenditure|Transfers|losses|31 Dec 2023| |£|£|£|£|£|£| |Designated| |Research Fund|1,234,912|59,808|-|(500,000)|28,542|823,262| |General Funds|236,116|747,512|(950,053)|500,000|5,457|539,032| |--------------------------------------------------|---------------------------------------|--------------------------------------|--------------------------------------|---------------------------------|--------------------------------------------------| |1,471,028|807,320|(950,053)|-|33,999|1,362,294| |=============================== =============================|=================================|==============================|===============================|=================================|

----- End of picture text -----

18. ANALYSIS OF NET ASSETS BETWEEN FUNDS

==> picture [428 x 203] intentionally omitted <==

----- Start of picture text -----
|||||| |---|---|---|---|---| |At 31 December 2024|Intangible|Net current| |fixed assets Investments|assets|Total| |£|£|£|£| |Restricted Funds|-|426,069|96,087|522,156| |Unrestricted Funds|7,032|1,189,015|35,218|1,231,265| |-----------------------------------------------|-----------------------------------------------|-----------------------------------------------|-----------------------------------------------| |Total Funds|7,032|1,615,084|131,305|1,753,421| |===============================================|===============================================|===============================================|===============================================| |At 31 December 2023|Intangible|Net current| |fixed assets|Investments|assets|Total| |£|£|£|£| |Restricted Funds|-|-|502,694|502,694| |Unrestricted Funds|14,064|1,386,998|-38,768|1,362,294| |-----------------------------------------------|-----------------------------------------------|-----------------------------------------------|-----------------------------------------------| |Total Funds|14,064|1,386,998|463,186|1,864,248| |====================================|====================================|==================================== ====================================|

----- End of picture text -----

- 42 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2024

18. ANALYSIS OF NET ASSETS BETWEEN FUNDS (CONTINUED)

Total unrealised gains as at 31 December 2024 constitute movements on revaluation and are as follows:

	2024	2023
	£	£
Unrealised gains included above:
On investments	110,029	33,999
	-------------------------------------	-------------------------------------
Total unrealised gains at 31 December	110,029	33,999
	=====================================	=====================================
Reconciliation of movements on unrealised gains:
Unrealised gains at 1 January	194,033	160,034
Add: Net gains arising on revaluations in the year	110,029	33,999
	---------------------------------------	---------------------------------------
Total unrealised gains at 31 December	304,062	194,033
	=============================================	=============================================

19. RECONCILIATION OF NET INCOME TO NET CASH USED IN OPERATING ACTIVITIES

	2024	2023
	£	£
Net movement in funds (as per the statement of
financial activities)	(111,826)	289,051
Depreciation/amortisation	7,032	7,032
Income from investments	(85,337)	(71,243)
Interest receivable	(759)	(1,694)
(Gains) on investments	(71,605)	(33,999)
Decrease (increase) in debtors	367,480	(351,243)
(Decrease) Increase in creditors	(11,545)	37,033
	-------------------------------------	-------------------------------------
Net cash used in operating activities	93,440	(125,063)
	===============	===============

20. ANALYSIS OF CHANGES IN NET DEBT

	1 Jan 24	Cash flows	31 Dec 24
	£	£	£
Cash in hand and at bank	60,900	23,054	83,954
	====================================	==========================================	========================================

- 43 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2024

21 . PENSION SCHEME

The Association participates in the Superannuation Arrangements of the University of London (“SAUL”), which is a centralised defined benefit scheme within the United Kingdom and was contracted out of the Second State Pension (prior to April 2016).

SAUL is an independently managed pension scheme for the non-academic staff of over 50 colleges and institutions with links to higher education.

Pension benefits accrued within SAUL currently build up on a Career Average Revalued Earnings (“CARE”) basis.

The Association is not expected to be liable to SAUL for any other current participating employer’s obligations under the Rules of SAUL, but in the event of an insolvency of any participating employer within SAUL, an amount of any pension shortfall (which cannot otherwise be recovered) in respect of that employer, may be spread across the remaining participating employers and reflected in the next actuarial valuation.

Funding Policy

SAUL’s statutory funding objective is to have sufficient and appropriate assets to meet the costs incurred by the Trustee in paying SAUL’s benefits as they fall due (the “Technical Provisions”). The Trustee adopts assumptions which, taken as a whole, are intended to be sufficiently prudent for pensions and benefits already in payment to continue to be paid and for the commitments which arise from Members’ accrued pension rights to be met.

The Technical Provisions assumptions include appropriate margins to allow for the possibility of events turning out worse than expected. However, the funding method and assumptions do not completely remove the risk that the Technical Provisions could be insufficient to provide benefits in the future.

A formal actuarial valuation of SAUL is carried out every three years by a professionally qualified and independent actuary. The last actuarial valuation was carried out with an effective date of 31 March 2023. Informal reviews of SAUL’s position, reflecting changes in market conditions, cash flow information and new accrual of benefits, are carried out between formal valuations.

The funding principles were agreed by the Trustee and employers in June 2021 and will be reviewed again at SAUL’s next formal valuation in 2026.

At the 31 March 2023 valuation SAUL was 105% funded on its Technical Provisions basis. The cost of accrual was 19.3% versus member and employer contributions of 27%, the difference being known as the contribution buffer.

The Trustee, Employers and SAUL negotiating committee also agreed to a package of measures to reduce the contribution buffer, with Employers decreasing their contributions from 21% to 19% on 1 September 2024, and to increase the annual cap on CPI pension increases in payment for future accrual from 2.5% to 5% from April 2025. As a result of these changes the contribution buffer will reduce to 3.7% of Salaries when these changes have taken effect.

Employer pension contributions charged to the statement of financial activities during the year amounted to £22,815 (2023: £21,388).

- 44 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2024

21 . PENSION SCHEME (CONTINUED)

Accounting Policy

The Association is a Participating Employer in SAUL. The actuarial valuation applies to SAUL as a whole and does not identify surpluses or deficits applicable to individual employers. As a whole, the market value of SAUL’s assets at 31 March 2023 was £3,096 million representing 105% of the liabilities. The market value of SAUL’s assets at 31 March 2023 was £3,072 million representing 109% of the estimated liabilities.

It is not possible to identify an individual Employer’s share of the underlying assets and liabilities of SAUL. The Association accounts for its participation in SAUL as if it were a defined contribution scheme and pension costs based on the amounts actually paid (i.e cash amounts) in accordance with paragraphs 28.11 of FRS 102.

The valuation as at 31 March 2023 noted a Technical Provisions surplus. Therefore, no deficit contributions were required following the 2023 valuation and there is no defined benefit liability (i.e the present value of any deficit contributions due to SAUL) to be recognised by the Association.

22 . RELATED PARTY TRANSACTIONS

One Officer of Council received £39,114, (2023: one Officer received £35,537) for services as Council members provided to the Association. No trustees received any remuneration for their services as trustees. During the year, Council members were reimbursed for travel and subsistence expenses incurred or paid for by the charity on their behalf in attending Council and other relevant meetings totalling £10,069, (2023: £26,407), of which four (2023: five) trustees received £4,476 (2023: £20,014).

During the year ended 31[st] December 2024, the Association was invoiced £3,950 (2023: £3,595) by S Brennan for graphic design services. S Brennan is the spouse of the Association’s Senior Administrator who is also a member of the key management personnel. At the year end the Association owed S Brennan £665, (2023: £nil). The transactions were made on terms equivalent to those that prevail in arm’s length transactions.

Prizes awarded during the year included the Down Surgical Prize, this prize, of £1,000 was awarded to C Newlands (Council) in 2023 (presented in 2024) .

- 45 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

MANAGEMENT INFORMATION

YEAR ENDED 31 DECEMBER 2024

The following pages do not form part of the statutory financial statements which are the subject of the independent auditor's report

- 46 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

DETAILED STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2024

	2024	2023
	£	£
INCOME FROM DONATIONS
Donations	-	397,965
INCOME FROM
INVESTMENTS
Income from UK listed investments	85,337	71,243
Bank interest receivable on short term cash deposits	759	1,694
	------------------------------------	------------------------------------
	86,096	72,937
	------------------------------------	------------------------------------
CHARITABLE ACTIVITIES
Subscription income from members	156,794	167,754
Journal income	301,950	330,676
Annual scientific meeting income	299,963	235,953
	------------------------------------	------------------------------------
	758,707	734,383
	------------------------------------	------------------------------------
	------------------------------------	------------------------------------
TOTAL	844,803	1,205,285
	------------------------------------	------------------------------------
EXPENDITURE ON
INVESTMENT MANAGEMENT COSTS
Investment management fees	16,888	12,433
	--------------------------------------	------------------------------------

- 47 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

DETAILED STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2024

==> picture [430 x 460] intentionally omitted <==

----- Start of picture text -----
|||| |---|---|---| |2024|2023| |£|£| |CHARITABLE ACTIVITIES| |Staff costs - Wages & Salaries|112,372|102,350| |Staff costs - Employer's NIC|7,997|6,552| |Staff costs - Pension costs|22,815|21,388| |Establishment – Rent and rates|17,131|13,999| |Amortisation|7,032|7,032| |JTG conference costs and JT (MRCS) programme|7,190|28,960| |Website development and maintenance costs|9,527|8,301| |AAOMS/Overseas BAOMS Presidents|1,757|14,281| |Strategic costs / PR Officer|8,669|3,167| |Grants, awards and prizes|138,228|42,856| |Cost of providing journals to members|151,415|158,861| |Annual Scientific Meeting expenditure|237,797|239,150| |Committee, council and senate expenses|40,750|38,081| |Chairman of council and deputy chair costs|39,114|35,537| |Presidents annual fund|23,821|35,090| |Other office costs|7,297|5,600| |Irrecoverable VAT expense|51,224|35,118| |Bookkeeping|14,860|11,515| |Communications|1,232|3,048| |Bank interest and charges|11,511|9,161| |Audit fees|11,500|10,250| |Audit advisory fees|-| |QOMS|64,346|84,875| |BAOMS membership operating system|15,527|15,779| |Publications|8,234|6,850| |------------------------------------|------------------------------------| |1,011,346|937,800| |------------------------------------|------------------------------------| |------------------------------------|------------------------------------| |NET (EXPENDITURE)/SURPLUS FOR THE| |YEAR|(183,431)|255,052| |BEFORE GAINS ON INVESTMENTS|===================================|=================== ================|

----- End of picture text -----

- 48 -

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

DETAILED STATEMENT OF FINANCIAL ACTIVITIES

YEAR ENDED 31 DECEMBER 2024

	2024	2023
	£	£
CHARITABLE ACTIVITIES
Costs of disseminating information on the
speciality
*Activities undertaken directly*
JTG conference costs and JT (MRCS) programme	7,190	28,960
ASiT	3,000	3,000
OMFS Illustrated guide	5,234	3,850
Amortisation	7,032	7,032
Website development and maintenance costs	9,527	8,301
QOMS	64,346	84,875
Strategic costs/ PR Officer	8,669	3,167
Cost of providing journals to members	151,415	158,861
Annual Scientific Meeting expenditure	237,797	239,150
Committee, council and senate expenses	40,750	38,081
Chairman of council and deputy chair costs	39,114	35,537
Presidents annual fund	23,821	35,090
BAOMS membership operating system	15,527	15,779
AAOMS/Overseas BAOMS Presidents	1,757	14,281
Grants, awards and prizes	138,228	42,856
	------------------------------------	------------------------------------
	753,407	718,820
	------------------------------------	------------------------------------
*Support costs*
Staff costs - Wages & Salaries	112,732	102,350
Staff costs - Employer's NIC	7,997	6,552
Staff costs - Pension costs	22,815	21,388
Establishment – Rent and rates	17,131	13,999
Other office costs	7,297	5,600
Irrecoverable VAT expense	51,224	35,118
Bookkeeping	14,860	11,515
Communications	1,232	3,048
Bank interest and charges	11,511	9,161
Audit fees	11,500	10,250
	------------------------------------	------------------------------------
	257,939	218,981
	------------------------------------	------------------------------------
	1,011,346	937,800
	===================================	=================== ================

- 49 -

2024-12-31-accounts

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

FINANCIAL STATEMENTS 31 DECEMBER 2024

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

FINANCIAL STATEMENTS

YEAR ENDED 31 DECEMBER 2024

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

REFERENCE AND ADMINISTRATIVE DETAILS

Trustees and Directors

The Council of the Association

Officers of Council

Members of Council

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

REFERENCE AND ADMINISTRATIVE DETAILS (continued)

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT

Status and History

Organisational Structure and Key Management

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Organisational Structure and Key Management (continued)

Method of Recruitment, Appointment, Election, Induction and Training of Trustees

Recruitment

Appointment and Election

Induction and Training

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Risk and Corporate Governance Matters

Statement of Trustees’ Responsibilities

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

STATEMENT OF TRUSTEES’ RESPONSIBILITIES (continued)

Statement of Trustees’ Responsibilities (continued)

Auditor

Statement as to Disclosure of Information to the Auditor

Professional Indemnity Insurance

OBJECTIVES AND ACTIVITIES

Charitable Objectives

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

Charitable Activities

Indicators, Milestones and Benchmarks

Public Benefit

Benefits and Beneficiaries

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

OBJECTIVES AND ACTIVITIES (continued)

Public Benefit (continued)

Trustees’ Assessment of Public Benefit

Grant Making Policy

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

OBJECTIVES AND ACTIVITIES (continued)

Research and Travel Grants

Representation on Other Bodies

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE

Activities, Events and their Impact

BAOMS Journals: BJOMS and ADOMS

THE BRITISH ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

TRUSTEES’ ANNUAL REPORT

YEAR ENDED 31 DECEMBER 2024

ACHIEVEMENTS AND PERFORMANCE (continued)